Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy Clinical research trials and Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy. Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy clinical trial. Participants frequently get the best healthcare available for their Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "P" Clinical Trials Conditions > Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy



Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

For Condition: IGA Glomerulonephritis
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) , Stanford University
Synopsis: OBJECTIVES: I. Determine the most sensitive outcome measures (functional or morphological) of a progressive renal injury in patients with IgA nephropathy. II. Determine which of these patients are destined to progress to further injury in order to target them for therapy. III. Elucidate the determinants of progression in those patients who exhibit evidence of either increasing impairment of ultrafiltration capacity or ongoing destruction of nephrons.
Details: PROTOCOL OUTLINE: Patients receive oral enalapril daily. Treatment continues for 5 years in the absence of unacceptable toxicity. Patients undergo renal function studies every 6-12 months for 5 years. Patients undergo renal biopsy at 36-48 months after study entry.
Eligibility:
Study Type:  Interventional, Treatment
Minimum Age/Maximum Age: 13 Years/60 Years
Genders: Both
Protocol Entry Criteria: Histologically confirmed IgA nephropathy, diagnosed within the past 3 years Clinical presentation of either isolated hematuria/proteinuria for less than 3 years OR Acute nephritic or nephrotic syndrome No secondary forms of IgA nephropathy associated with chronic inflammatory disease of the bowel and liver No end stage renal failure as defined by the following: Glomerular filtration rate less than 15 mL/min AND Extensive glomerulosclerosis and tubulointerstitial damage No systemic lupus erythematosus or systemic (extrarenal) vasculitis (Henoch-Schonlein syndrome) Healthy volunteers will be accrued as a control group No other concurrent medical or psychiatric illness that would preclude study
Total Enrollment: 43

Location and Contact Information:

Overall Study Official:
BryanMyers,  Study Chair,  Stanford University


Additional Information:
Study ID Numbers:  199/15244;  SUMC-GCRC-5R01DK49372
Study Start Date: May 2000
Record last reviewed: September 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006137

Other Iga Glomerulonephritis Studies:
1. Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

2. Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis

3. Alternate Day Prednisone or Daily Fish Oil Supplements in Patients with Immunoglobulin A Nephropathy

Related Studies:

Other IGA Glomerulonephritis Clinical Trials
Other Clinical Trials
Other Clinical Trials

Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy
Modify your Search

  Other IGA Glomerulonephritis Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103